TNF and inflammatory bowel disease: The published English articles related to the efficacy of TNF blockades for the AS-associated IBD manifestation are demonstrated in Table 2 with the enrolled cases dominant in the Caucasian race from Europe and North America, and most studies examine the effect of infliximab (IFX) and ETA with an open-label design12–28.